DATATRAK International, Inc. DTRK
Set alert
0.29 USD -0.01 -3.33%
At close · Oct 30
0.29 Day range 0.29
0.17 52-week range 0.99
- YTD
- -21.62%
- 1 year
- -67.78%
- Open
- 0.29
- Prev close
- 0.30
- Mkt cap
- 8.03M
- Vol
- 5.00K
- Avg vol
- 1.52K
- EPS
- -0.09
- P/E
- 0.00
More statistics
- Low
- 0.29
- High
- 0.29
YTD chart
Signals (34)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| RSI: Overbought | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| RSI: Oversold | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| RSI: Overbought | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| RSI: Oversold | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
Newest 20 of 34.
Financials — quick view
DTRK Revenue — quarterly 2.09M
DTRK Net income — quarterly -787.87K
DTRK EPS — quarterly -0.72
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2022 | Sep 1, 2022 | 0.00 | -0.10 | — | — |
| Aug 14, 2022 | Jun 1, 2022 | 0.00 | -0.11 | — | — |
| Nov 15, 2021 | Sep 1, 2021 | 0.00 | -0.18 | — | — |
| Aug 13, 2021 | Jun 1, 2021 | 0.00 | 0.21 | — | — |
| May 5, 2021 | Mar 1, 2021 | 0.00 | 0.00 | — | — |
| Mar 26, 2021 | Dec 1, 2020 | 0.00 | -0.04 | — | — |
News
- DATATRAK Standalone eConsent Accelerates Clinical Trials
- Vuzix (NASDAQ:VUZI) vs. Datatrak International (OTCMKTS:DTRK) Financial Survey
- CRO Selects Datatrak eSource for $1,800,000 Contract
- CRO Selects Datatrak eTMF & ePRO for $6,600,000 Contract
- Global CRO Switches to Datatrak eTMF for All its Clinical Trial Documentation and Processes
- European CRO Commits to Datatrak eClinical Technology Platform for All-In-One Clinical Trial Data Solutions for eSource, EDC, RTSM, eTMF, CTMS, eConsent, and ePRO
- eClinical Solutions Market and Companies Analysis Report 2025: Features Key Players Anju Software, BioClinicia, Parexel International Corporation, CRF Health, and Datatrak International
- Datatrak International, Inc. Discusses Potential of Its eClinicial and Predictive Analytics Platforms with The Stock Day Podcast
- Datatrak International, Inc. Reports Results for Second Quarter and First Half of 2021
- Datatrak International, Inc. Reports First Quarter Results for 2021
Your note
Sign in to keep a note on DTRK — it syncs with the Stock Master app.